Final-Program-ATS-2023-AP.vp

TUESDAY • MAY 23

225

BEHAVIORAL • CLINICAL • TRANSLATIONAL MINI SYMPOSIUM

CLINICAL MINI SYMPOSIUM

C15

C16

EMERGING COPD DIAGNOSTICS AND TREATMENTS

THE ROAD TO RECOVERY: IMPROVING LONG-TERM OUTCOMES AFTER CRITICAL ILLNESS

9:00 a.m. - 11:00 a.m.

Walter E. Washington Convention Center Ballroom B (Level 3)

9:00 a.m. - 11:00 a.m.

Walter E. Washington Convention Center Room 143 A-C (Street Level)

Chairing: M.B. Drummond, MHS, MD, ATSF, Chapel Hill, NC J. Bon, MD, MS, ATSF, Pittsburgh, PA A.A. Lambert, MD, MHS, Spokane, WA Oral Presentations: 9:00 Clinical Consequences of Race Correction in PFTS: Comparison of the GLI Race-specific Coefficients With Use of Aggregate “Other” Category/ D. Vyas, Boston, MA 9:12 Pi-slope: A New Method for Quantifying Airway Disease/ S.P. Bhatt, Birmingham, AL 9:24 Recombinant Human Alpha-1 Antitrypsin (AAT) Protein INBRX-101 Demonstrates Potential to Achieve Lung Penetration and Normal Functional Serum AAT Levels in Patients With AAT Deficiency/ B.T. Kuhn, Sacramento, CA 9:36 Alvelestat, an Oral Neutrophil Elastase Inhibitor in Alpha-1 Antitrypsin Deficiency (AATD): Results of a Phase II Trial/ R.A. Stockley, Birmingham, United Kingdom 9:48 Ensifentrine, a Novel Dual Phosphodiesterase (PDE) 3 and 4 Inhibitor, Improves Lung Function and Reduces Exacerbation Rate and Risk in Phase 3 Enhance-2 Trial/ A. Anzueto, San Antonio, TX 10:00 Objectively Recorded Peak Inspiratory Flow (PIF), Inhalation Volume and Reliever Medication Use Preceding COPD Exacerbations/ J.A. Ohar, Winston Salem, NC 10:12 Vital Signs Remote Patient Monitoring in Real-life for Early Detection of Acute Exacerbations of Chronic Obstructive Pulmonary Disease/ Y. Le Guillou, Cesson Sevigné, France 10:24 The Impact of a Care Signature Pathway on COPD Hospitalizations/ C.L. Rochester, New Haven, CT 10:36 Scottish Patients Living Remotely and Rurally, With Acute Exacerbations of Chronic Obstructive Pulmonary Disease, Can Have Safe, Effective, Person-Centred Care in Their Own Home Through Innovative Use of Technology/ R. Cooper, Inverness, United Kingdom 10:48 Early Detection of Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD) Using At-home Lung Oscillometry/ N. Hickman, Ventura, CA

Chairing: K.C. Vranas, MD, MSCR, Portland, OR D.K. Costa, PhD, RN, Orange, CT S.D. Halpern, MD, PhD, Philadelphia, PA Oral Presentations: 9:00 Physician Recommendations in the Setting of Code Status Discussions: A Multi-centre Cohort Study/ R.G. Melvin, Toronto, Canada 9:12 Family Member Role in Goal-concordant Care in the Intensive Care Unit (ICU)/ W. Kiker, Seattle, WA 9:24 Addressing Unmet Needs Among Family Members of Critically Ill Patients: The ICUconnect Randomized Clinical Trial/ C.E. Cox, Durham, NC 9:36 Post-tracheostomy Healthcare Trajectory for Patients With Acute Respiratory Failure/ A.B. Mehta, Denver, CO 9:48 Associations Between ICU Mobility Dose, Disability, and Quality of Life After Critical Illness/ M.F. Mart, Nashville, TN 10:00 Physical Activity During Critical Illness and Subsequent Disability in Survivors of Critical Illness/ N.E. Brummel, Columbus, OH 10:12 Collaboration With Survivors of Critical Illness to Support Long-term Recovery: An Experienced Based Co-design Study/ A. Da Silva, Parkville, Australia 10:24 The Association Between the Childhood Opportunity Index and the Social Vulnerability Index and Recovery After Pediatric Acute Respiratory Distress Syndrome/ E. Rinaldi, Los Angeles, CA 10:36 “Mind The Gap” - Improving the Integration Between Primary and Intensive Care After Critical Illness (Integrate) Study/ N. Leggett, Footscray, Australia 10:48 The Canadian COVID-19 Prospective Cohort Study/ M.S. Herridge, Toronto, Canada

ATS 2023 • Washington, DC